These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36370475)

  • 1. Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy.
    Khalilimeybodi A; Riaz M; Campbell SG; Omens JH; McCulloch AD; Qyang Y; Saucerman JJ
    J Mol Cell Cardiol; 2023 Jan; 174():1-14. PubMed ID: 36370475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy.
    Khalilimeybodi A; Saucerman JJ; Rangamani P
    Comput Biol Med; 2024 Jun; 175():108499. PubMed ID: 38677172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
    Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
    Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM; Poley RN; Ny M; Tester DJ; Xu X; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Mol Genet Metab; 2006 May; 88(1):78-85. PubMed ID: 16352453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Hayashi T; Arimura T; Itoh-Satoh M; Ueda K; Hohda S; Inagaki N; Takahashi M; Hori H; Yasunami M; Nishi H; Koga Y; Nakamura H; Matsuzaki M; Choi BY; Bae SW; You CW; Han KH; Park JE; Knöll R; Hoshijima M; Chien KR; Kimura A
    J Am Coll Cardiol; 2004 Dec; 44(11):2192-201. PubMed ID: 15582318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
    Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
    Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.
    Riaz M; Park J; Sewanan LR; Ren Y; Schwan J; Das SK; Pomianowski PT; Huang Y; Ellis MW; Luo J; Liu J; Song L; Chen IP; Qiu C; Yazawa M; Tellides G; Hwa J; Young LH; Yang L; Marboe CC; Jacoby DL; Campbell SG; Qyang Y
    Circulation; 2022 Apr; 145(16):1238-1253. PubMed ID: 35384713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.
    Li X; Lu WJ; Li Y; Wu F; Bai R; Ma S; Dong T; Zhang H; Lee AS; Wang Y; Lan F
    Cell Death Dis; 2019 Aug; 10(8):610. PubMed ID: 31406109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
    Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
    Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac titin and heart disease.
    LeWinter MM; Granzier HL
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):207-12. PubMed ID: 24072177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
    Waldmüller S; Erdmann J; Binner P; Gelbrich G; Pankuweit S; Geier C; Timmermann B; Haremza J; Perrot A; Scheer S; Wachter R; Schulze-Waltrup N; Dermintzoglou A; Schönberger J; Zeh W; Jurmann B; Brodherr T; Börgel J; Farr M; Milting H; Blankenfeldt W; Reinhardt R; Özcelik C; Osterziel KJ; Loeffler M; Maisch B; Regitz-Zagrosek V; Schunkert H; Scheffold T;
    Eur J Heart Fail; 2011 Nov; 13(11):1185-92. PubMed ID: 21750094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
    Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
    Seeger T; Shrestha R; Lam CK; Chen C; McKeithan WL; Lau E; Wnorowski A; McMullen G; Greenhaw M; Lee J; Oikonomopoulos A; Lee S; Yang H; Mercola M; Wheeler M; Ashley EA; Yang F; Karakikes I; Wu JC
    Circulation; 2019 Feb; 139(6):799-811. PubMed ID: 30586709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.
    Mori H; Xu D; Shimoda Y; Yuan Z; Murakata Y; Xi B; Sato K; Yamamoto M; Tajiri K; Ishizu T; Ieda M; Murakoshi N
    Sci Rep; 2024 Jul; 14(1):15422. PubMed ID: 38965264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review.
    Eschenhagen T; Carrier L
    Pflugers Arch; 2019 May; 471(5):755-768. PubMed ID: 30324321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
    Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.
    Bhagwan JR; Mosqueira D; Chairez-Cantu K; Mannhardt I; Bodbin SE; Bakar M; Smith JGW; Denning C
    J Mol Cell Cardiol; 2020 Aug; 145():43-53. PubMed ID: 32531470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating myosin-binding protein C and titin abnormalities to whole-heart function using a novel calcium-contraction coupling model.
    Arts T; Lyon A; Delhaas T; Kuster DWD; van der Velden J; Lumens J
    J Mol Cell Cardiol; 2024 May; 190():13-23. PubMed ID: 38462126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.